Cargando…
CD73(+) Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
With multipotent differentiation potential and paracrine capacity, mesenchymal stem cells (MSCs) have been widely applied in clinical practice for the treatment of ischemic heart disease. MSCs are a heterogeneous population and the specific population of MSCs may exhibit a selective ability for tiss...
Autores principales: | Li, Qiong, Hou, Huifang, Li, Meng, Yu, Xia, Zuo, Hongbo, Gao, Jianhui, Zhang, Min, Li, Zongjin, Guo, Zhikun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152667/ https://www.ncbi.nlm.nih.gov/pubmed/34055772 http://dx.doi.org/10.3389/fcell.2021.637239 |
Ejemplares similares
-
Cardiac Derived CD51-Positive Mesenchymal Stem Cells Enhance the Cardiac Repair Through SCF-Mediated Angiogenesis in Mice With Myocardial Infarction
por: Xie, Dong Mei, et al.
Publicado: (2021) -
Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
por: Sun, Chuang, et al.
Publicado: (2021) -
Isolation and Multiple Differentiation of Rat Pericardial Fluid Cells
por: Sun, Ying, et al.
Publicado: (2021) -
Ecto-5′-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells
por: Rosemblatt, Mariana V., et al.
Publicado: (2021) -
CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity
por: Briceño, Pedro, et al.
Publicado: (2021)